Zobrazeno 1 - 10
of 18
pro vyhledávání: '"L. A. Everse"'
Autor:
Ger J. A. Arkesteijn, Willem van Eden, Elmieke P. J. Boot, L. A. Everse, Esther N. M. Nolte-‘t Hoen, Gert Storm, Josée P A Wagenaar-Hilbers, Marca H. M. Wauben, Jolanda H. M. van Bilsen
Publikováno v:
Journal of Leukocyte Biology. 83:112-121
Major problems in the analysis of CD4+ effector cell and regulatory T cell (Treg) populations in an activated immune system are caused by the facts that both cell types can express CD25 and that the discriminatory marker forkhead box p3 can only be a
Publikováno v:
Scopus-Elsevier
IL-2 and IL-12 are promising anti-tumour agents. However, little attention has been paid to the role of macrophages during IL-2/IL-12 mediated tumour rejection. We studied the role of macrophages during IL-2/IL-12 mediated tumour rejection in DBA/2 m
Autor:
Hub F.J. Dullens, Monique R. Bernsen, L. A. Everse, A.W. van der Velden, W. Den Otter, A. P. M. Heintz
Publikováno v:
Cancer Immunology, Immunotherapy. 46:41-47
To establish whether or not local low-dose recombinant interleukin-2 (rIL-2) therapy might result in therapeutic benefit for ovarian cancer patients treated with cisplatin, the antitumour effects of rIL-2 and of combined treatment with cisplatin and
Autor:
Monique R. Bernsen, Ludo J. Hellebrekers, L. A. Everse, Cas L. J. J. Kruitwagen, W. Den Otter, P. L. P. Van Loo, Vera Baumans
Publikováno v:
Laboratory Animals. 31:318-325
During the last decades, an increase is apparent in the use of analgesics for laboratory animals in situations where this was previously considered unnecessary. Mice with advanced tumours often show clear signs of discomfort which may be a result of
Autor:
Ingrid B. Renes, D.H. Rutgers, Willem Den Otter, Hub F.J. Dullens, Monique R. Bernsen, Ina M. Jürgenliemk-Schulz, Jan J. Battermann, L. A. Everse
Publikováno v:
International Journal of Cancer. 72:1003-1007
Tumor recurrence and outgrowth of metastases limit the therapeutical effect of radiotherapy. We have tested whether these problems can be overcome by supplementing radiotherapy with locoregional interleukin-2 (IL-2) treatment. The SL2 lymphoma and th
Autor:
Monique R. Bernsen, D.H. Rutgers, Jan J. Battermann, L. A. Everse, W. Den Otter, Ina M. Jürgenliemk-Schulz, I.B. Renes
Publikováno v:
Radiation Oncology Investigations. 5:54-61
The aim of this work was to improve radiotherapy results by immune stimulation. We tested the effects of a combination of radio- and immunotherapy, i.e., local low dose recombinant interleukin-2 (rIL-2) treatment, in two murine tumor models. Syngenei
Autor:
L. A. Everse, J. A. J. Faber, W. Den Otter, A. Hamburg, K.E.W.P. Tan, Annette C. Moll, D. A. E. Lindenmayer, J. W. Koten
Publikováno v:
Scopus-Elsevier
The histopathology of 61 eyes was studied with special attention to the morphology of the retina adjacent to the main tumour. Three retinal types were distinguished. Retina type 1 (RT-1, 28 specimens) contained a single tumour that was sharply demarc
Publikováno v:
Scopus-Elsevier
Cancer treatment with IL-2 and IL-12 is thought to work via enhancement of proliferation and activity of T cells and NK cells. Incubation of cytotoxic T lymphocytes (CTLs) and NK cells with IL-2 and/or IL-12 results in propagation of a distinct cell
Autor:
Wim Jiskoot, Gerben A. Koning, Carmen Arigita, Jan G. J. van de Winkel, Daan J.A. Crommelin, Gideon F.A. Kersten, Wim E. Hennink, Martine Van Vugt, L. A. Everse, Lisette Bevaart
Publikováno v:
Infection and immunity. 71(9)
The effect of targeting strategies for improving the interaction of liposomal PorA with dendritic cells (DC) on the immunogenicity of PorA was investigated. PorA, a major antigen of Neisseria meningitidis , was purified and reconstituted in different
Publikováno v:
Transplantation. 71(5)
Graft versus host disease (GVHD) mediated by allogeneic donor T cells may be initiated and/or exacerbated by residual host antigen presenting cells (APC) which survive the transplant conditioning regimen. We examined whether the depletion of hepatic